Empowering communities in combating river blindness and the role of NGOs: case studies from Cameroon, Mali, Nigeria, and Uganda

Health Research Policy and Systems

Volumn 10, Issue , 2012, Pages

  Meredith, Stefanie E O ^a   Cross, Catherine ^b   Amazigo, Uche V ^c  

^a Global health Consulting   (France)

^b Independent Consultant   (United Kingdom)

^c Independent Consultant   (Nigeria)

Author keywords

APOC, MDP; Community based; Community directed; Ivermectin distribution; NGO; Onchocerciasis

Indexed keywords

IVERMECTIN;

CAMEROON; COMMUNITY CARE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; INTERVIEW; MALI; METHODOLOGY; NIGERIA; ONCHOCERCIASIS; OUTCOME ASSESSMENT; PREVALENCE; REVIEW; UGANDA;

ANTIPARASITIC AGENTS; CAMEROON; COMMUNITY HEALTH SERVICES; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH POLICY; HUMANS; INTERNATIONAL COOPERATION; IVERMECTIN; MALI; NIGERIA; ONCHOCERCIASIS, OCULAR; ORGANIZATIONS; UGANDA;

EID: 84860676462     PISSN: None     EISSN: 14784505     Source Type: Journal    
DOI: 10.1186/1478-4505-10-16     Document Type: Review

References (49)

1. Benton B, Bump J, Sékétéli A, Liese B. Partnership and promise: evolution of the African river-blindness campaigns. Ann Trop Med Parasitol 2002, 96(Suppl 1):S5-S14.
2. Boatin B. The Onchocerciasis Control Programme in West Africa (OCP). Ann Trop Med Parasitol 2008, 102(Suppl 1):13-17.
3. Levine R. Millions Saved. Controlling onchcocerciais in Sub-Saharan-Africa 2007, Burlinton: Jones and Bartlett, Danvers R Levine.
4. Bush S, Hopkins AD. Public-private partnerships in neglected tropical disease control: the role of non- governmental organisations. Acta Trop 2011, 120(Suppl 1):S169-S172.
5. Remme JHF, Feenstra P, Lever PR, Medici AC, Morel CM, Noma M, Ramaiah KD, Richards F, Sékétéli A, Schmunis G, et al. Tropical Diseases Targeted for Elimination: Chagas Disease, Lymphatic Filariasis, Onchocerciasis, and Leprosy. Disease Control Priorities in Developing Countries 2006, Washington DC: The International Bank for Reconstruction and Development/The World Bank Group, Jamison DT.
6. Kim A. Health and Labour Productivity: the economic impact of onchocercal skin disease: Policy and research working paper 1836 1997, Washington: The World Bank.
7. WHO Onchocerciasis and its Control. In: WHO technical report series 1995, Geneva: World Health Organization, WHO.
8. Samba EM. The Onchocerciais Control Programme in West Africa 1994, Geneva: World Health Organization.
9. Sturchio J. Business engagement in public programs: the pharmaceutical industry's contribution to public health and the millennium development goals 2008, Bingley: Emerald Group Publishing Limited.
10. Haddad D, Cross C, Thylefors B, Richards FO. Bush S, Hopkins AD, Baker SK: Health care at the end of the road: opportunities from 20 years of partnership in onchocerciasis control. Glob Public Health 2008, 3(2):187-196.
11. Newland HS, White AT, Greene BM, D'Anna SA, Keyvan-Larijani E, Aziz MA, Williams PN, Taylor HR. Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement. Br J Ophthalmol 1988, 72(8):561-569.
12. Greene BM, White AT, Newland HS, Keyvan-Larijani E, Dukuly ZD, Gallin MY, Aziz MA, Williams PN, Taylor HR. Single dose therapy with ivermectin for onchocerciasis. Trans Assoc Am Physicians 1987, 100:131-138.
13. Pacque MC, Dukuly Z, Greene BM, Munoz B, Keyvan-Larijani E, Williams PN, Taylor HR. Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions. Bull World Health Organ 1989, 67(6):721-730.
14. WHO The Importance of Onchocercal Skin Disease: Report of a multi-country study by the Pan-African Study Group in Onchocercal Skin Disease 1995, Geneva: The World Health Organization, WHO.
15. Amazigo UO. Detrimental effects of onchocerciasis on marriage age and breast-feeding. Trop Geogr Med 1994, 46(5):322-325.
16. WHO APOC Magazine 2011, World health Organization, Geneva, available at http://www.who.int/entity/apoc/magazine_final_du_01_juillet_2011.pdf, WHO.
17. Katabarwa M, Eyamba A, Habomugisha P, Lakwo T, Ekobo S, Kamgno J, Kuete T, Ndyomugyenyi R, Onapa A, Salifou M, et al. After a decade of annual dose mass ivermectin treatment in Cameroon and Uganda, onchocerciasis transmission continues. Tropical medicine & international health : TM & IH 2008, 13(9):1196-1203.
18. Teckle EH AH, Isiyaku S, Amazigo UV, Bush S, Noma M, Cousens S, Abiose A, Remme JH. Impact of long-term treatmentt of onchocerciasis with ivermectin in Kaduna state, Nigeria: first evidence of the potential for elimination in the operationa area of the African Programme for Onchocerciais Control. Parasite and Vector 2012, 5:28.
19. Haddad D. The NGDO Co-ordination Group for Onchocerciasis Control. Ann Trop Med Parasitol 2008, 102(Suppl 1):35-38.
20. Amazigo U. The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2008, 102(Suppl 1):19-22.
21. Dadzie KY. Onchocerciasis control: the APOC strategy. Africa health 1997, 19(3):13-15.
22. Drameh PS, Richards FO, Cross C, Etya'ale DE, Kassalow JS. Ten years of NGDO action against river blindness. Trends Parasitol 2002, 18(9):378-380.
23. Sauerbrey M. The Onchocerciasis Elimination Program for the Americas (OEPA). Ann Trop Med Parasitol 2008, 102(Suppl 1):25-29.
24. Delisle H, Roberts J, Munro M, Jones L, Gyorkos T. The role of NGOs in global health research for development. Health Research Policy and Systems 2005, 3(1):3.
25. Lavis JN, Robertson D, Woodside JM, McLeod CB, Abelson J. How can research organizations more effectively transfer research knowledge to decision makers?. Milbank Q 2003, 81(2):221-248. 171-222.
26. Seketeli A, Adeoye G, Eyamba A, Nnoruka E, Drameh P, Amazigo UV, Noma M, Agboton F, Aholou Y, Kale OO, et al. The achievements and challenges of the African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2002, 96(Suppl 1):S15-28.
27. Alexander ND, Cousens SN, Yahaya H, Abiose A, Jones BR. Ivermectin dose assessment without weighing scales. Bull World Health Organ 1993, 71(3-4):361-366.
28. WHO Community Directed Treatment with Ivermectin 1996, Geneva: WHO, WHO.
29. Rougemont A, Boisson ME. Borges da Silva G, Zander N: [Attempt at a collective treatment with diethylcarbamazine in a village in the region of Bamako (Mali) where onchocerciasis is hyperendemic]. Bull World Health Organ 1976, 54(4):403-410.
30. De Sole G. Criterion for inclusion in onchocerciasis control programmes based on ivermectin distribution. Trans R Soc Trop Med Hyg 1995, 89(2):224-225.
31. Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF, et al. Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal. PLoS Negl Trop Dis 2009, 3(7):e497.
32. Budden FH. The epidemiology of onchocerciasis in Northern Nigeria. Trans R Soc Trop Med Hyg 1956, 50(4):366-378.
33. Budden FH. Blindness in Northern Nigeria. Br Med J 1952, 1(4770):1248.
34. Ogbuagu KF, Eneanya CI. A multi-centre study of the effect of Mectizan treatment on onchocercal skin disease: clinical findings. Ann Trop Med Parasitol 1998, 92(Suppl 1):S139-145.
35. Brieger WR, Awedoba AK, Eneanya CI, Hagan M, Ogbuagu KF, Okello DO, Ososanya OO, Ovuga EB, Noma M, Kale OO, et al. The effects of ivermectin on onchocercal skin disease and severe itching: results of a multicentre trial. Tropical medicine & international health : TM & IH 1998, 3(12):951-961.
36. Njepuome PO-P N, Okoronkwo C, Igbe M. Controlling Onchocerciasis: The Nigerian Experience. The Internet Journal of Parasitic Diseases 2009, Volume 4(Number 1).
37. Khemani S. Local Government accountability for health service delivery in Nigeria. Journal of African Economics 2005, 15(2):285-312.
38. Duke BO, Lewis DJ, Moore PJ. Onchocerca-Simulium complexes. I. Transmission of forest and Sudan-savanna strains of Onchocerca volvulus, from Cameroon, by Simulium damnosum from various West African bioclimatic zones. Ann Trop Med Parasitol 1966, 60(3):318-326.
39. Fuglsang H, Anderson J, Marshall TF. Studies on onchocerciasis in the United Cameroon Republic. V.A. four year follow-up of 6 rain-forest and 6-Sudan-savanna villages. Some changes in skin and lymph . nodesTransactions of the Royal Society of Tropical Medicine and Hygiene 1979, 73(1):118-119.
40. Renz A, Wenk P, Anderson J, Fuglsang H. Studies on the dynamics of transmission of onchocerciasis in a Sudan-savanna area of North Cameroon V. What is a tolerable level of Annual Transmission Potential?. Ann Trop Med Parasitol 1987, 81(3):263-274.
41. Ngoumou P, Walsh JF, Mace JM. A rapid mapping technique for the prevalence and distribution of onchocerciasis: a Cameroon case study. Ann Trop Med Parasitol 1994, 88(5):463-474.
42. Mace JM, Boussinesq M, Ngoumou P, Oye J E, Koeranga A, Godin C. Country-wide rapid epidemiological mapping of onchocerciasis (REMO) in Cameroon. Ann Trop Med Parasitol 1997, 91(4):379-391.
43. Twum-Danso NA, Meredith SE. Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Tropical medicine & international health : TM & IH 2003, 8(9):820-831.
44. Chippaux JP, Boussinesq M, Gardon J, Gardon-Wendel N, Ernould JC. Severe adverse reaction risks during mass treatment with ivermectin in loiasis-endemic areas. Parasitology today (Personal ed) 1996, 12(11):448-450.
45. Gardon J, Gardon-Wendel N, Demanga N, Kamgno J, Chippaux JP, Boussinesq M. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 1997, 350(9070):18-22.
46. Wanji S, Tendongfor N, Esum M, Yundze SS, Taylor MJ, Enyong P. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon. Filaria journal 2005, 4(1):2.
47. Fischer P, Kipp W, Bamuhiga J, Binta-Kahwa J, Kiefer A, Buttner DW. Parasitological and clinical characterization of Simulium neavei-transmitted onchocerciasis in western Uganda. Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ) 1993, 44(4):311-321.
48. Cupp EW, Guyer C, Sprenger TR, Unnasch TR. Importance of ivermectin to human onchocerciasis:past, present and the future. Research and reports in Tropical medicine 2011, 2:81-92.
49. Coffeng GF LE, Ozoh G, Bissek AC, Niatté BO, Enyong P, Olinga Olinga BM, Zouré HGM, Habbema JDF, Stolk WA, de Vlas SJ, Boussinesq M, Noma M. Concurrence of dermatological and ophthalmological morbidity in onchocerciasis. Trans R Soc Trop Med Hyg 2012, 106(4):245-251.